CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $1.43B, above the global median of $520.53M
- FinancialsAltman Z-Score 1.67: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.26%Above 5Y avg (1.11%)
Annual Rate
KRW 1500.00Paid annual
Payout Ratio
0.0%Sustainable
Payback Period
86.6 yr
Last Ex-Dividend
Mar 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.36TKRW956.17M · vs all stocks (USD)
Revenue (TTM)
2.04TKRW1.43B · vs all stocks (USD)
Profit Margin
-0.68%Beta
0.7480xvs all stocks
52-Week Change
-8.65%vs all stocks
Market Capitalization
1.36TKRW956.17M · vs all stocks (USD)
Enterprise Value
2.36TKRW1.65B · vs all stocks (USD)
Forward P/E
32.17xPrice to Sales (TTM)
0.6888xPrice to Book (MRQ)
1.04xEnterprise to Revenue
1.15xEnterprise to EBITDA
14.76xGross Margin
28.19%Profit Margin
-0.68%Operating Margin
2.69%Return on Assets (TTM)
1.54%Return on Equity (TTM)
-2.29%Revenue (TTM)
2.04TKRW1.43B · vs all stocks (USD)
Revenue per Share (TTM)
179.00KKRWUpdated Jul 14, 2026Quarterly Revenue Growth
13.50%Gross Profit (TTM)
562.64BKRW394.78M · vs all stocks (USD)
EBITDA (TTM)
218.67BKRW153.43M · vs all stocks (USD)
Net Income (TTM)
-13.90BKRW-9.75M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-31.10%Operating Cash Flow (TTM)
161.14BKRW113.07M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
94.64BKRW66.41M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.50KKRWUpdated Jul 14, 2026Trailing Annual Dividend Yield
1.26%vs all stocks
5-Year Average Dividend Yield
1.11%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
176.80BKRWFY2025 · Dec 31, 2025Revenue
1.99TKRWFY2025 · Dec 31, 2025Cost of Goods Sold
1.44TKRWFY2025 · Dec 31, 2025Gross Profit
554.12BKRWFY2025 · Dec 31, 2025Operating Income
69.15BKRW48.52M · vs all stocks (USD)
Pre-tax Income
-35.33BKRWFY2025 · Dec 31, 2025Income Tax Expense
-5.65BKRWFY2025 · Dec 31, 2025Net Income
-29.69BKRWFY2025 · Dec 31, 2025EBIT
14.97BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
212.83BKRWFY2025 · Dec 31, 2025Research & Development
152.94BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
166.30BKRWFY2025 · Dec 31, 2025Other Operating Expenses
7.22BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
2.83BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
50.30BKRWFY2025 · Dec 31, 2025EPS (Basic)
-410.00KRWFY2025 · Dec 31, 2025EPS (Diluted)
-410.00KRWFY2025 · Dec 31, 2025Basic Shares Outstanding
11.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
11.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-29.69BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
25.01BKRWFY2025 · Dec 31, 2025Operating Cash Flow
-130.11BKRWFY2025 · Dec 31, 2025Free Cash Flow
-200.36BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
49.37BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-29.69BKRWFY2025 · Dec 31, 2025Other Non-cash Items
47.74BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-20.84BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-127.32BKRWFY2025 · Dec 31, 2025Capital Expenditures
-70.25BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-31.79BKRWFY2025 · Dec 31, 2025Net Acquisitions
-105.67BKRWFY2025 · Dec 31, 2025Purchase of Investments
-69.41BKRWFY2025 · Dec 31, 2025Sale of Investments
85.99BKRWFY2025 · Dec 31, 2025Other Investing Activity
957.11MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-158.38BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
166.85BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-1.08TKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-27.41BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-18.83BKRWFY2025 · Dec 31, 2025Other Financing Charges
136.15MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-959.73BKRWFY2025 · Dec 31, 2025Shares Outstanding
11.41MSharesUpdated Jul 14, 2026Float Shares
5.45MSharesUpdated Jul 14, 2026% Held by Insiders
51.44%vs all stocks
% Held by Institutions
14.21%vs all stocks
Total Cash (MRQ)
42.73BKRW29.98M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.74KKRWUpdated Jul 14, 2026Total Debt (MRQ)
914.33BKRW641.55M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6985xCurrent Ratio (MRQ)
1.25xBook Value per Share (MRQ)
114.69KKRWUpdated Jul 14, 2026Total Assets
2.97TKRW2.08B · vs all stocks (USD)
Total Current Assets
1.37TKRWFY2025 · Dec 31, 2025Total Liabilities
1.58TKRWFY2025 · Dec 31, 2025Total Non-current Assets
1.60TKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
431.02BKRWFY2025 · Dec 31, 2025Total Current Liabilities
1.15TKRWFY2025 · Dec 31, 2025Cash
49.37BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
49.37BKRWFY2025 · Dec 31, 2025Other Short-term Investments
1.43BKRWFY2025 · Dec 31, 2025Accounts Receivable
402.69BKRWFY2025 · Dec 31, 2025Inventory
891.58BKRWFY2025 · Dec 31, 2025Accounts Payable
177.26BKRWFY2025 · Dec 31, 2025Short-term Debt
623.55BKRWFY2025 · Dec 31, 2025Other Current Liabilities
30.30BKRWFY2025 · Dec 31, 2025Long-term Debt
358.60BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
1.12BKRWFY2025 · Dec 31, 2025Common Stock (Book)
58.43BKRWFY2025 · Dec 31, 2025Retained Earnings
796.53BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
1.39TKRW978.31M · vs all stocks (USD)
Treasury Stock
35.70BKRWFY2025 · Dec 31, 202552-Week Low
115.90KKRWUpdated Jul 14, 202652-Week High
183.80KKRWUpdated Jul 14, 202652-Week Change
-8.65%vs all stocks
Beta
0.7480xvs all stocks
50-Day MA
130.49KKRWUpdated Jul 14, 2026200-Day MA
143.69KKRWUpdated Jul 14, 2026Avg 10-Day Volume
42.50KSharesUpdated Jul 14, 2026Avg 30-Day Volume
46.13KSharesUpdated Jul 14, 2026Diluted EPS (TTM)
-410.00KRWUpdated Jul 14, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.67: grey zoneSignificant
Altman Z-Score: 1.67
Low earnings qualitySignificant
Earnings Quality Score: -2.88
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $1.43B, above the global median of $520.53MNotable
Revenue (USD): 1,433,514,093.576Global Median: 520,528,949.311
Levered free cash flow is $66.41M, above the global median of $16.24MNotable
Levered free cash flow (USD): 66,407,761.568Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Youcare Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hob Biotech Group Suzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Annexon, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Tong Ren Tang Chinese Medicine Company Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Kura Oncology Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Suven Life Sciences Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Guizhou Bailing Group Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Seegene, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Kanghua Biological Products Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow